- Q2 2024 Eris Lifesciences Ltd Earnings Call TranscriptNov 08, 2023₹897.8 (+3.30%)Earnings
- Q1 2024 Eris Lifesciences Ltd Earnings Call TranscriptAug 07, 2023₹828.2 (+3.45%)Earnings
- Q4 2023 Eris Lifesciences Ltd Earnings Call TranscriptMay 17, 2023₹636.65 (+1.06%)Earnings
- Eris Lifesciences Ltd to Announce Acquisition of Nine Dermatology Brands From Dr Reddy's Laboratories Ltd Call TranscriptMar 16, 2023
- Q3 2023 Eris Lifesciences Ltd Earnings Call TranscriptJan 17, 2023₹651.8 (+0.50%)Earnings
- Q2 2023 Eris Lifesciences Ltd Earnings Call TranscriptOct 20, 2022₹707.85 (-2.92%)Earnings
- Q1 2023 Eris Lifesciences Ltd Earnings Call TranscriptAug 05, 2022₹694.75 (-0.81%)Earnings
- Q4 2022 Eris Lifesciences Ltd Earnings Call TranscriptMay 04, 2022₹663.35 (-1.86%)Earnings
- Q3 2022 Eris Lifesciences Ltd Earnings Call TranscriptJan 28, 2022₹696.2 (-2.04%)Earnings
- Eris Lifesciences Ltd To Discuss Joint Venture with Mj Biopharm Pvt Ltd Call TranscriptDec 04, 2021
- Q2 2022 Eris Lifesciences Ltd Earnings Call TranscriptOct 29, 2021₹821 (+4.73%)Earnings
- Q1 2022 Eris Lifesciences Ltd Earnings Call TranscriptJul 29, 2021₹771.15 (+3.91%)Earnings
- Q4 2021 Eris Lifesciences Ltd Earnings Call TranscriptMay 13, 2021₹653.85Earnings
- Q3 2021 Eris Lifesciences Ltd Earnings Call TranscriptJan 28, 2021₹623.1 (+2.03%)Earnings
- Q2 2021 Eris Lifesciences Ltd Earnings Call TranscriptNov 03, 2020₹518.1 (+1.46%)Earnings
- Q1 2021 Eris Lifesciences Ltd Earnings Call TranscriptAug 04, 2020₹510.95 (-5.48%)Earnings
- Q4 2020 Eris Lifesciences Ltd Earnings Call TranscriptJun 02, 2020₹519.2 (-1.59%)Earnings
- Q3 2020 Eris Lifesciences Ltd Earnings Call TranscriptFeb 14, 2020₹465.5 (-11.33%)Earnings
- Q2 2020 Eris Lifesciences Ltd Earnings Call TranscriptNov 07, 2019₹425.55 (+4.61%)Earnings
- Q1 2020 Eris Lifesciences Ltd Earnings Call TranscriptJul 29, 2019₹394.8 (-1.62%)Earnings
- Q4 2019 Eris Lifesciences Ltd Earnings Call TranscriptMay 21, 2019₹605.6 (-1.37%)Earnings
Q4 2022 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Q4 and FY '22 Conference Call of Eris Life Sciences. We have with us on the call today Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you sir.
Thank you. Good afternoon, and welcome to our fourth quarter conference call. I'm Krishnakumar, and I'm happy to connect with you today. At the outset, I'm delighted to inform you that Eris has entered the elite club of Indian pharma companies to have crossed INR 400 crores of profit after tax in just 15 years from inception. There are less than a handful of pharma companies in these categories. We have delivered an EPS growth of 14% in this financial year on the back of a 21% EPS growth, which we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)